Hi Baldy
The common cold has eluded many great companies in the past and one I hope this company wouldn’t waste time and money on unless already making substantial money elsewhere. sepsis is the fastest way to market for rce. I agree it is a good decision to go the sepsis pathway as it is becoming a burden on hospitals and obviously patients lives. Hopefully once approved for sepsis it could start to be used for other common bacterial infections without the need for extended trials. However I don’t know enough about the process that would need to be followed to see if that was possible. I feel confident human trials will be granted by the FDA and if the trials are successful on safety it wouldn’t last long before being swallowed up by a large pharma
- Forums
- ASX - By Stock
- Accelerated Approval for RECCE® 327
Hi Baldy The common cold has eluded many great companies in the...
-
- There are more pages in this discussion • 83 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RCE (ASX) to my watchlist
|
|||||
Last
48.0¢ |
Change
0.005(1.05%) |
Mkt cap ! $110.0M |
Open | High | Low | Value | Volume |
47.5¢ | 48.0¢ | 47.5¢ | $6.42K | 13.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 71707 | 47.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
48.0¢ | 65381 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 71707 | 0.475 |
3 | 9641 | 0.470 |
4 | 50404 | 0.465 |
2 | 19143 | 0.460 |
5 | 30769 | 0.455 |
Price($) | Vol. | No. |
---|---|---|
0.480 | 65381 | 2 |
0.485 | 92787 | 2 |
0.490 | 41287 | 3 |
0.495 | 4324 | 1 |
0.500 | 1100 | 1 |
Last trade - 10.07am 22/08/2024 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |